An Artificial Copper‐Michaelase Featuring a Genetically Encoded Bipyridine Ligand for Asymmetric Additions to Nitroalkenes
Angewandte Chemie International Edition · 17.04.2025 · 64 (17)
DOI: 10.1002/anie.202423182 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 25.02.2025. Verfasst von Ru Jiang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Stratingh Institute for Chemistry, University of Groningen, Nijenborgh 3, 9747 AG, Groningen, The Netherlands. Hauptthemen laut MEDLINE: Copper, Alkenes, Nitro Compounds, Pyridines. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: H2020 European Research Council, H2020 Marie Skłodowska-Curie Actions, European Synchrotron Radiation Facility.
Abstract (Originalsprache)
Artificial metalloenzymes (ArMs) are an attractive approach to achieving “new to nature” biocatalytic transformations. In this work, a novel copper‐dependent artificial Michaelase (Cu_Michaelase) comprising a genetically encoded copper‐binding ligand, i. e. (2,2‐bipyridin‐5‐yl)alanine (BpyA), was developed. For the first time, such an ArM containing a non‐canonical metal‐binding amino acid was successfully optimized through directed evolution. The evolved Cu_Michaelase was applied in the copper‐catalyzed asymmetric addition of 2‐acetyl azaarenes to nitroalkenes, yielding various γ‐nitro butyric acid derivatives, which are precursors for a range of high‐value‐added pharmaceutically relevant compounds, with good yields and high enantioselectivities (up to >99 % yield and 99 % ee). Additionally, the evolved variant could be further used in a preparative‐scale synthesis, providing chiral products for diverse derivatizations. X‐ray crystal structure analysis confirmed the binding of Cu(II) ions to the BpyA residues and showed that, in principle, there is sufficient space for the 2‐acetyl azaarene substrate to coordinate. Kinetic studies showed that the increased catalytic efficiency of the evolved enzyme is due to improvements in apparent K M for both substrates and a notable threefold increase in apparent k cat for 2‐acetyl pyridine. This work illustrates the potential of artificial metalloenzymes exploiting non‐canonical metal‐binding ligands for new‐to‐nature biocatalysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Stratingh Institute for Chemistry, University of Groningen, Nijenborgh 3, 9747 AG, Groningen, The Netherlands.
- Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, Nijenborgh 3 4, 9747 AG, Groningen, The Netherlands.
ORCID-Profile: Ru Jiang, Fabrizio Casilli, Andy-Mark W H Thunnissen, Gerard Roelfes
Förderung
- H2020 European Research Council
- H2020 Marie Skłodowska-Curie Actions
- European Synchrotron Radiation Facility
Zitieren
APA
Jiang, R., Casilli, F., Thunnissen, A. W. H., & Roelfes, G. (2025). An Artificial Copper‐Michaelase Featuring a Genetically Encoded Bipyridine Ligand for Asymmetric Additions to Nitroalkenes. Angewandte Chemie International Edition, 64(17). https://doi.org/10.1002/anie.202423182
Vancouver
Jiang R, Casilli F, Thunnissen AWH, Roelfes G. An Artificial Copper‐Michaelase Featuring a Genetically Encoded Bipyridine Ligand for Asymmetric Additions to Nitroalkenes. Angewandte Chemie International Edition. 2025;64(17). doi:10.1002/anie.202423182
BibTeX
@article{Jiang2025,
author = {Jiang, Ru and Casilli, Fabrizio and Thunnissen, Andy-Mark W H and Roelfes, Gerard},
title = {An Artificial Copper‐Michaelase Featuring a Genetically Encoded Bipyridine Ligand for Asymmetric Additions to Nitroalkenes},
journal = {Angewandte Chemie International Edition},
year = {2025},
volume = {64},
number = {17},
doi = {10.1002/anie.202423182}
}
EUVIMED